Last reviewed · How we verify
Risperidone ISM — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Risperidone ISM (Risperidone ISM) — Rovi Pharmaceuticals Laboratories.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Risperidone ISM TARGET | Risperidone ISM | Rovi Pharmaceuticals Laboratories | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Risperidone ISM CI watch — RSS
- Risperidone ISM CI watch — Atom
- Risperidone ISM CI watch — JSON
- Risperidone ISM alone — RSS
Cite this brief
Drug Landscape (2026). Risperidone ISM — Competitive Intelligence Brief. https://druglandscape.com/ci/risperidone-ism. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab